Chemically Programmed Immunity
Chemically Programmed Immunity
批准号:
8512581
负责人:
CARLOS F BARBAS
金额:
$91.18万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-30 至 2015-07-31
关键词:
AntibodiesBiomedical ResearchCellsChemicalsDevelopmentDiseaseFlu virusGoalsHIV-1ImmuneImmune systemImmunityImmunoglobulinsInfection preventionLearningNatural ImmunityReceptor SignalingScientistT-LymphocyteTherapeuticToll-like receptorsVaccinesVirusabstractingacquired immunityarmcancer therapyfluinsightinterestmacrophagemeetingsnovelnovel strategiesnovel vaccinespathogenpillprogramsprophylacticresponsetumor
中文摘要
描述
英文摘要
DESCRIPTION
Abstract:
Imagine calling T-cells, macrophages, and antibodies into action by taking a simple pill that instantaneously programs both adaptive and innate arms of the immune system to attack a tumor or virus, preventing infection and halting disease. Such an approach could meet major unmet challenges in biomedical research and therapy. My goal is to develop novel approaches that allow innate and acquired immunity to be purposefully targeted to pathogens of interest. These studies build on recently revealed mechanisms of Toll-like receptor signaling, ideas concerning approaches of targeting their sensing abilities to pathogens of defined interest and insights gained from our own invention of chemically programmed antibodies. Ultimately, these studies will allow scientists to program a variety of immune cells and responses to attack pathogens of interest using a variety of mechanisms. We will apply these results to studies in cancer therapy. Furthermore, we will explore novel approaches that should allow for circulating immunoglobulins induced with covalent vaccines to be programmed to inhibit HIV-1 and flu virus entry. The vaccines that result from these studies may be of both prophylactic and therapeutics utility. I will develop novel chemical approaches aimed at learning how to purposefully target innate immunity, T- cells, and macrophages to defined pathogens. I will apply these developments to create new cancer therapies. I will develop a novel approach to orally available chemically programmed immunity. I will apply developments in orally available chemically programmed immunity towards new vaccine strategies for HIV-1 and flu.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multifunctional Human Anti-HIV Antibodies
-
批准号:8233982
-
项目类别:
-
资助金额:$47.38万
-
财政年份:2011
-
负责人:CARLOS F BARBAS
-
依托单位:
Multifunctional Human Anti-HIV Antibodies
-
批准号:8427351
-
项目类别:
-
资助金额:$44.53万
-
财政年份:2011
-
负责人:CARLOS F BARBAS
-
依托单位:
Multifunctional Human Anti-HIV Antibodies
-
批准号:8138731
-
项目类别:
-
资助金额:$47.38万
-
财政年份:2011
-
负责人:CARLOS F BARBAS
-
依托单位:
Chemically Programmed Immunity
-
批准号:8318204
-
项目类别:
-
资助金额:$94.0万
-
财政年份:2010
-
负责人:CARLOS F BARBAS
-
依托单位:
Chemically Programmed Immunity
-
批准号:7979974
-
项目类别:
-
资助金额:$94.95万
-
财政年份:2010
-
负责人:CARLOS F BARBAS
-
依托单位:
Chemically Programmed Immunity
-
批准号:8146099
-
项目类别:
-
资助金额:$94.0万
-
财政年份:2010
-
负责人:CARLOS F BARBAS
-
依托单位:
Zinc Finger Recombinases for Endogenous Genome Tailoring
-
批准号:7673561
-
项目类别:
-
资助金额:$25.16万
-
财政年份:2008
-
负责人:CARLOS F BARBAS
-
依托单位:
Zinc Finger Recombinases for Endogenous Genome Tailoring
-
批准号:7500623
-
项目类别:
-
资助金额:$20.97万
-
财政年份:2008
-
负责人:CARLOS F BARBAS
-
依托单位:
A Selective Approach to Metastatic Gene Discovery
-
批准号:6963726
-
项目类别:
-
资助金额:$23.24万
-
财政年份:2005
-
负责人:CARLOS F BARBAS
-
依托单位:
A Selective Approach to Metastatic Gene Discovery
-
批准号:7140359
-
项目类别:
-
资助金额:$22.69万
-
财政年份:2005
-
负责人:CARLOS F BARBAS
-
依托单位:
Chemically Programmed Antibodies for Cancer Therapy
-
批准号:7104283
-
项目类别:
-
资助金额:$30.06万
-
财政年份:2004
-
负责人:CARLOS F BARBAS
-
依托单位:
Chemically Programmed Antibodies for Cancer Therapy
-
批准号:6823398
-
项目类别:
-
资助金额:$30.78万
-
财政年份:2004
-
负责人:CARLOS F BARBAS
-
依托单位:
Chemically Programmed Antibodies for Cancer Therapy
-
批准号:7231670
-
项目类别:
-
资助金额:$29.19万
-
财政年份:2004
-
负责人:CARLOS F BARBAS
-
依托单位:
Chemically Programmed Antibodies for Cancer Therapy
-
批准号:7895802
-
项目类别:
-
资助金额:$31.01万
-
财政年份:2004
-
负责人:CARLOS F BARBAS
-
依托单位:
Chemically Programmed Antibodies for Cancer Therapy
-
批准号:7429816
-
项目类别:
-
资助金额:$29.47万
-
财政年份:2004
-
负责人:CARLOS F BARBAS
-
依托单位:
Chemically Programmed Antibodies for Cancer Therapy
-
批准号:6934554
-
项目类别:
-
资助金额:$30.78万
-
财政年份:2004
-
负责人:CARLOS F BARBAS
-
依托单位:
Chemically Programmed Antibodies for Cancer Therapy
-
批准号:7730648
-
项目类别:
-
资助金额:$31.01万
-
财政年份:2004
-
负责人:CARLOS F BARBAS
-
依托单位:
Transcriptional Blockades of HIV-1
-
批准号:6656772
-
项目类别:
-
资助金额:$30.03万
-
财政年份:2003
-
负责人:CARLOS F BARBAS
-
依托单位:
Transcriptional Blockades of HIV-1
-
批准号:6743625
-
项目类别:
-
资助金额:$30.03万
-
财政年份:2003
-
负责人:CARLOS F BARBAS
-
依托单位:
Transcriptional Blockades of HIV-1
-
批准号:7061196
-
项目类别:
-
资助金额:$29.33万
-
财政年份:2003
-
负责人:CARLOS F BARBAS
-
依托单位:
海外基金